Literature DB >> 31825072

Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.

Pa Saidou Chaw1, Lei Hua2, Steve Cunningham3, Harry Campbell2, Rafael Mikolajczyk1, Harish Nair2,4.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is among the most important causes of acute lower respiratory tract infection (ALRI) in young children. We assessed the severity of RSV-ALRI in children less than 5 years old with bronchopulmonary dysplasia (BPD).
METHODS: We searched for studies using EMBASE, Global Health, and MEDLINE. We assessed hospitalization risk, intensive care unit (ICU) admission, need for oxygen supplementation and mechanical ventilation, and in-hospital case fatality (hCFR) among children with BPD compared with those without (non-BPD). We compared the (1) length of hospital stay (LOS) and (2) duration of oxygen supplementation and mechanical ventilation between the groups.
RESULTS: Twenty-nine studies fulfilled our inclusion criteria. The case definition for BPD varied substantially in the included studies. Risks were higher among children with BPD compared with non-BPD: RSV hospitalization (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.7-4.2; P < .001), ICU admission (OR, 2.9; 95% CI, 2.3-3.5; P < .001), need for oxygen supplementation (OR, 4.2; 95% CI, .5-33.7; P = .175) and mechanical ventilation (OR, 8.2; 95% CI, 7.6-8.9; P < .001), and hCFR (OR, 12.8; 95% CI, 9.4-17.3; P < .001). Median LOS (range) was 7.2 days (4-23) (BPD) compared with 2.5 days (1-30) (non-BPD). Median duration of oxygen supplementation (range) was 5.5 days (0-21) (BPD) compared with 2.0 days (0-26) (non-BPD). The duration of mechanical ventilation was more often longer (>6 days) in those with BPD compared with non-BPD (OR, 11.9; 95% CI, 1.4-100; P = .02).
CONCLUSIONS: The risk of severe RSV disease is considerably higher among children with BPD. There is an urgent need to establish standardized BPD case definitions, review the RSV prophylaxis guidelines, and encourage more specific studies on RSV infection in BPD patients, including vaccine development and RSV-specific treatment.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute lower respiratory infections; bronchopulmonary dysplasia; chronic lung disease; respiratory syncytial virus

Year:  2020        PMID: 31825072     DOI: 10.1093/infdis/jiz492

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.

Authors:  Wenzhang Liang; Yue Zhang; Miao Li; Fadhl Al-Shaebi; Jian Li; Jing Zhang; Lin Wei
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 2.  Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants.

Authors:  Tong Sun; Haiyang Yu; Jianhua Fu
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

3.  In-hospital respiratory viral infections for patients with established BPD in the SARS-CoV-2 era.

Authors:  Matthew J Kielt; Angela Murphy; Jodi Smathers; MaLeah Bates; Leif D Nelin; Edward G Shepherd
Journal:  Pediatr Pulmonol       Date:  2021-10-12

4.  Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study).

Authors:  Katrin Hartmann; Johannes G Liese; Daniel Kemmling; Christiane Prifert; Benedikt Weißbrich; Pushpike Thilakarathne; Joris Diels; Karin Weber; Andrea Streng
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759

5.  Murine Neonatal Oxidant Lung Injury: NRF2-Dependent Predisposition to Adulthood Respiratory Viral Infection and Protection by Maternal Antioxidant.

Authors:  Hye-Youn Cho; Laura Miller-DeGraff; Ligon A Perrow; Wesley Gladwell; Vijayalakshmi Panduri; Fred B Lih; Steven R Kleeberger
Journal:  Antioxidants (Basel)       Date:  2021-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.